AstraZeneca’s roxadustat reveals positive results against anaemia
Drug Discovery | News | 0 Comment | 25 Jul, 2019
AstraZeneca has announced that data from two Phase III trials evaluating the efficacy and safety of roxadustat in China....Read more
Sosei Heptares teams up with Genentech for multi-target R&D
Drug Discovery | News | 0 Comment | 17 Jul, 2019
Japan headquartered Sosei Group Corporation has entered into a multi-target research collaboration and license agreement...Read more
Eisai collaborates with University of Dundee for cancer drug discovery
Drug Discovery | News | 0 Comment | 09 Jul, 2019
Japanese pharmaceutical firm Eisai Co.,Ltd. has announced that it has entered into a collaboration research agreement wi...Read more
New Vaccine in the Treatment of Rheumatoid Arthritis
Drug Discovery | News | 0 Comment | 09 Jul, 2019
CEL-SCI Corporation (NYSE American: CVM) announced that one of its key collaborators from Rush University Medi...Read more
Singapore HSA approves Vosevi to treat Chronic Hepatitis C Virus
Drug Discovery | News | 1 Comment | 25 Jun, 2019
Gilead Sciences, Inc., on 24 June 2019, announced that the Singapore Health Sciences Authority (HAS) has approved Vosevi...Read more
Gilead collaborates with Nurix to develop new cancer therapies
Drug Discovery | News | 0 Comment | 21 Jun, 2019
Gilead Sciences and Nurix Therapeutics, Inc., have announced a global strategic collaboration to discover, dev...Read more
Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules
Drug Discovery | News | 0 Comment | 17 Jun, 2019
Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the ...Read more
Acucela gets EMA approval for Emixustat to treat Stargardt disease
Drug Discovery | News | 0 Comment | 11 Jun, 2019
Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharm...Read more
Sosei Heptares to receive new $3 million milestone payment from Pfizer
Drug Discovery | News | 0 Comment | 10 Jun, 2019
Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their mult...Read more
CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
Drug Discovery | News | 0 Comment | 10 Jun, 2019
CStone Pharmaceuticals, on 9 June 2019, announced its global clinical collaboration with China focus with Baye...Read more
Luye Pharma's Rykindo gets NDA filing acceptance by USFDA
Drug Discovery | News | 0 Comment | 30 May, 2019
Rykindo® (LY03004), Luye Pharma's innovative, independently developed Extended-Release Microspheres f...Read more
Sihuan Pharm achieves new grant approval
Drug Discovery | News | 0 Comment | 28 May, 2019
Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular (CCV) drug manufacturer in China's&...Read more
BGU introduces Novel Combination Therapy for treating neurological disorders
Drug Discovery | News | 0 Comment | 13 May, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduces a novel drug comb...Read more
Taiwan Health Ministry approves Vemlidy for chronic hepatitis B
Drug Discovery | News | 0 Comment | 30 Apr, 2019
Gilead Sciences, Inc. has recently announced that with effect from 1 May 2019, Vemlidy (tenofovir alafenamide, TAF)...Read more
ADC Therapeutics and Adagene announce discovery collaboration agreement
Drug Discovery | News | 0 Comment | 25 Apr, 2019
ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary ...Read more
Roche launches Emicizumab in India
Drug Discovery | News | 0 Comment | 21 Apr, 2019
Roche has declared that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with factor VIII in...Read more
Japan grants Sakigake designation to Eisai’s novel FGFR
Drug Discovery | News | 0 Comment | 08 Apr, 2019
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...Read more
Takeda takes step towards EU Entyvio extension
Drug Discovery | News | 0 Comment | 02 Apr, 2019
Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...Read more